135 related articles for article (PubMed ID: 12948930)
1. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
Peris K; Micantonio T; Fargnoli MC
Eur J Dermatol; 2003; 13(4):413-4; author reply 415. PubMed ID: 12948930
[No Abstract] [Full Text] [Related]
2. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
Dendorfer M; Oppel T; Wollenberg A; Prinz JC
Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
Tanghetti E; Werschler P
J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
[No Abstract] [Full Text] [Related]
5. Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.
Tsikeloudi M; Lallas A; Sidiropoulos T; Chasioti V; Lefaki I; Apalla Z
Clin Exp Dermatol; 2014 Jan; 39(1):60-2. PubMed ID: 23773180
[No Abstract] [Full Text] [Related]
6. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
Jorizzo J; Dinehart S; Matheson R; Moore JK; Ling M; Fox TL; McRae S; Fielder S; Lee JH
J Am Acad Dermatol; 2007 Aug; 57(2):265-8. PubMed ID: 17512087
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck.
Olsen EA; Abernethy ML; Kulp-Shorten C; Callen JP; Glazer SD; Huntley A; McCray M; Monroe AB; Tschen E; Wolf JE
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):738-43. PubMed ID: 1869646
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod cream in the treatment of actinic keratoses.
Persaud A; Lebwohl M
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study.
Misiewicz J; Sendagorta E; Golebiowska A; Lorenc B; Czarnetzki BM; Jablonska S
J Am Acad Dermatol; 1991 Mar; 24(3):448-51. PubMed ID: 2061443
[TBL] [Abstract][Full Text] [Related]
11. Treating actinic keratoses with imiquimod.
Dixon A
Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
13. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream.
Di Lernia V; Ricci C; Albertini G
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):626-9. PubMed ID: 15324413
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
16. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
D'Addario S; Carrington PR
Acta Derm Venereol; 2006; 86(4):366-7. PubMed ID: 16874431
[No Abstract] [Full Text] [Related]
17. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
18. Topical imiquimod in the treatment of large facial keratoacanthomas.
Cecchi R; Bartoli L; Brunetti L; Pavesi M
G Ital Dermatol Venereol; 2012 Oct; 147(5):505-7. PubMed ID: 23007258
[No Abstract] [Full Text] [Related]
19. Imiquimod as a possible treatment for keratoacanthoma.
Bhatia N
J Drugs Dermatol; 2004; 3(1):71-4. PubMed ID: 14964750
[TBL] [Abstract][Full Text] [Related]
20. Detection and treatment of preclinical actinic keratoses (PAK).
Kopera D; Kerl H
J Dtsch Dermatol Ges; 2010 Sep; 8(9):693-4. PubMed ID: 20561117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
